Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 7 Lymphoma, B-Cell 4 Lymphoma, Follicular 3 Lymphoma 3 Lymphoma, Mantle-Cell 2 Waldenstrom Macroglobulinemia 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 53 Vincristine 33 blinatumomab 30 Prednisone 28 Methotrexate 28 Cytarabine 26 Dexamethasone 24 Specimen Handling 21 Rituximab 21 Doxorubicin 20 merphos 19 Mercaptopurine 19 Etoposide 18 prednylidene 17 fludarabine 17 deltacortene 17 Calcium Dobesilate 17 Biopsy 17 dexamethasone acetate 16 dexamethasone 21-phosphate 16 auricularum 16 N,N-dicyclohexyl-isoborneol-10-sulfonamide 16 azathiopurine 15 Inotuzumab Ozogamicin 15 pegaspargase 14 venetoclax 13 Leucovorin 13 CT-P10 13 Asparaginase 13 Spinal Puncture 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Burkitt Lymphoma × loncastuximab tesirine × 1 year × Clear all

NCT05270057 2025-10-09

LONCA

Medical College of Wisconsin

Phase 1 Active not recruiting

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡